Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03964350 · ClinicalTrials.gov registry record · Early Phase 1
Behavior Brain Responses
A Early Phase 1 study, sponsored by University of Chicago.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT03964350 is a Early Phase 1 study that has completed, run by University of Chicago. The registered enrollment target is 30 participants.
The verdict
NCT03964350, a Early Phase 1 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
To compare responses to acute oral doses of ethanol in healthy young adults who experience mainly stimulant subjective effects from the drug or mainly sedative effects.
Interventions
- OTHER Placebo
- DRUG Ethanol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2020-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03964350
The ClinicalTrials.gov registry entry for NCT03964350 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03964350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03964350 about?
NCT03964350 is a clinical study titled "Behavior Brain Responses". To compare responses to acute oral doses of ethanol in healthy young adults who experience mainly stimulant subjective effects from the drug or mainly sedative effects.
What is the current status of trial NCT03964350?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2019-05-28. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03964350?
The interventions under investigation include: Placebo (OTHER), Ethanol (DRUG).
Who is sponsoring clinical trial NCT03964350?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.